13F Pro Quality Score

77.5/100

Rank #82 of 2,879 stocksTOP 5%

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

81.7/100

Profitability

93.7/100

Balance Sheet

97.6/100

Earnings Quality

80.2/100

Free Cash Flow

90.7/100

Institutional Flow

68.4/100

Revenue Scale

41.8/100

Dilution Risk

9.7/100

DOCS Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Doximity, Inc. (DOCS), a Technology sector company. 13F Pro's AI-powered ranking engine scores DOCS at 77.5/100 on a 32-signal composite quality model, placing it at rank #82 of 2,879 stocks — the top 5% of the AI-ranked universe. DOCS scores in the top quartile across balance sheet strength (97.6), profitability (93.7), free cash flow (90.7). Shareholder dilution risk is elevated at 9.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q4 2026), Doximity, Inc. reports quarterly revenue of $145.4M, net income of $19.1M, free cash flow of $109.5M. Top institutional holders of DOCS by reported 13-F value include BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. DOCS trades on the NYSE exchange and files with the SEC under CIK 1516513. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DOCS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Doximity, Inc. directly from SEC EDGAR. Doximity, Inc.'s 13F Pro composite quality score has ranged between 8 and 84 since 2022, currently 77.5 — a stable long-term trajectory across 51 quarterly and live scoring snapshots.

Fun facts about Doximity, Inc.

Quirks, history, and lore behind DOCS — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. software-as-a-service company · mid-cap · listed on NYSE · headquartered in San Francisco, California.
  • 2
    The Numbers
    Annual revenue in the range of $400–500 million with impressively high gross margins typical of pure SaaS — and a customer base measured in hundreds of thousands, not millions.
  • 3
    The History
    Founded in 2010 by two physicians who were frustrated that doctors still networked and shared information like it was the fax machine era.
  • 4
    The Secret
    Its platform is essentially LinkedIn for licensed clinicians — membership is gated, meaning you must hold a U.S. medical license to get in the door.
  • 5
    The Lore
    It reached profitability unusually fast for a tech company and is known for having an extraordinarily lean workforce relative to its revenue — a source of both admiration and raised eyebrows on Wall Street.
  • 6
    The Giveaway
    More than 80% of U.S. physicians are members of this professional network built exclusively for doctors — making it the de-facto digital hub of American medicine.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q4 2026

$145.4M

Net Income

Q4 2026

$19.1M

Free Cash Flow

Q4 2026

$109.5M

Get alerted when DOCS's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Doximity, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of DOCS

Put DOCS on your watchlist

Track score changes the day Doximity, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is DOCS a good stock to buy?

13F Pro's AI-powered analysis of Doximity, Inc. (DOCS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for DOCS are available on the DOCS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own DOCS?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling DOCS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Doximity, Inc.'s investment landscape.